04/01/2015 - 11:47am

Dr. Reddy's Laboratories on Wednesday acquired UCB's portfolio of dermatology, respiratory and pediatric products. 

04/01/2015 - 10:54am

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

03/31/2015 - 3:57pm

The director of the FDA’s Office of Generic Drugs temporarily steps down to deal with a medical issue, according to a report by the Regulatory Focus Professionals Society.

03/31/2015 - 10:39am

Amneal Pharmaceuticals will acquire Actavis Australia's generic pharmaceutical business. Financial terms of the agreement were not disclosed. 

03/31/2015 - 9:29am

Teva Pharmaceutical Industries announced the launch of generic Exforge (amlodipine and valsartan) tablets, which are indicated for the treatment of hypertension. 

 

03/30/2015 - 10:50am

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.

03/27/2015 - 10:51am

The Food and Drug Adminisration on Friday revisited the issue of supplemental applications proposing labeling changes for approved drugs and biologic products. 

03/24/2015 - 3:40pm

Apotex' Jeff Watson elected to chair the Canadian Generic Pharmaceutical Association on Monday.

03/24/2015 - 1:26pm

Actavis last week announced that its acquisition of Allergan has been completed in a transaction valued at $70.5 billion, a deal that creates one of the world’s top 10 pharmaceutical companies by sales revenue, according to the company.